alzhub.org
Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

Home › Research › Clinical trials

Clinical trials

Every Alzheimer's trial in our copy of the ClinicalTrials.gov registry — completed, running and abandoned. Filter it, then follow the link to the official record.

If you are thinking about joining a trial

A listing here is a record that a study was registered. It is not a recommendation, and it does not mean the study is still recruiting or that anyone is eligible. Registry entries go stale.

Talk to the treating doctor first, then contact the study team listed on the official ClinicalTrials.gov record. The NIA's free referral line can help you look: 1-800-438-4380, weekdays, English and Spanish.

Clear filters Download all 7,816 as CSV

"Open to new participants" means the registry status is RECRUITING or NOT_YET_RECRUITING — 1,523 of the 7,816 records. That is what the sponsor last told the registry, which can be months out of date.
Location is by country. This pull of the registry records the countries a study runs in, not its individual sites, so we cannot filter by US state or city — and we are not going to guess one. To find the nearest site, open a trial's record below: the official page lists every location with its contact details.

Showing 7,026–7,050 of 7,816 matching trials · page 282 of 313, 25 per page.

Sorted by the date the registry record was last updated, newest first. This page never loads all 7,816 rows at once — use the CSV download if you want the whole file.

Registered Alzheimer's clinical trials. Every ID links to its official ClinicalTrials.gov record.
Trial Phase Status Enrolled Sponsor Last updated
A Two-part Multiple Dose Study to Assess the Safety and Effects of AZD3293 in Healthy Elderly and Alzheimer's Patients
NCT01795339
AZD3293; Placebo
Runs in: United States · 1 site 		PHASE1
other		 COMPLETED 47 AstraZeneca
INDUSTRY		 2014-04-03
A Study of Characterizing Cognitive Decline and Functional Cardiac Senescence in Healthy Korean Volunteers
NCT01590706
Runs in: South Korea · 1 site 		NA
other		 COMPLETED 116 Korea Institute of Oriental Medicine
OTHER_GOV		 2014-04-02
Inadequate Emergence After Laparoscopic Surgery in Trendelemburg Position
NCT02101671
Runs in: Spain · 1 site 		NA
other		 UNKNOWN 140 Corporacion Parc Tauli
OTHER		 2014-04-02
Multicentric Trial of the Treatment of Huntington's Disease by Cysteamine (RP103)
NCT02101957
RP103; Placebo
Runs in: France · 1 site 		PHASE2|PHASE3
other		 UNKNOWN 96 University Hospital, Angers
OTHER_GOV		 2014-04-02
Media Impact on Preschool Behavior
NCT01459835
media diet; nutritional intervention
Runs in: United States · 1 site 		NA
other		 COMPLETED 600 Seattle Children's Hospital
OTHER		 2014-03-26
Evaluation of Efficacy and Safety of Galantamine in Patients With Dementia of Alzheimer's Type Who Failed to Benefit From Donepezil
NCT01478633
Galantamine
Runs in: Japan · 11 sites 		PHASE4
symptomatic-cholinergic		 COMPLETED 102 Janssen Pharmaceutical K.K.
INDUSTRY		 2014-03-26
A Retrospective Analysis of Cerefolin NAC® in Cognitively Impaired Patients
NCT01594541
Runs in: United States · 1 site 		NA
other		 UNKNOWN 700 Pamlab, Inc.
INDUSTRY		 2014-03-24
Inappropriate Medications Associated With Anticholinesterase and/or Memantine Treatment in the Elderly
NCT00954616
Runs in: France · 6 sites 		NA
symptomatic-cholinergic		 COMPLETED 636 University Hospital, Limoges
OTHER		 2014-03-20
Oxytocin and Social Cognition in Frontotemporal Dementia
NCT01002300
intranasal oxytocin
Runs in: Canada · 1 site 		NA
other		 COMPLETED 24 London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
OTHER		 2014-03-18
A Study to Measure CSF Proteins in Elderly Healthy Volunteers and Volunteers With Mild Cognitive Impairment or Alzheimer's Disease
NCT01436188
Standard CSR sampling procedure; Alternate frequency CSR sampling p...
Runs in: Belgium; Netherlands · 3 sites 		EARLY_PHASE1
anti-inflammatory		 COMPLETED 5 Janssen Research & Development, LLC
INDUSTRY		 2014-03-18
Multi-Site Evaluation of Second Step
NCT01792167
Second Step Curriculum
Runs in: United States · 1 site 		NA
other		 UNKNOWN 4,089 University of Illinois at Urbana-Champaign
OTHER		 2014-03-18
The Effect of a 36-week Tablet-based Intervention on Multiple Domains in Older Adults With Mild Cognitive Impairment
NCT02087618
Kodro+; Kodro+D
Runs in: United States · 1 site 		NA
other		 UNKNOWN 50 Mt. Sinai Medical Center, Miami
OTHER		 2014-03-14
Observational Study Of Donepezil In Routine Clinical Practice
NCT00843115
donepezil 		NA
symptomatic-cholinergic		 TERMINATED 370 Pfizer
INDUSTRY		 2014-03-13
Efficacy of Pulsatile IV Insulin on Cognition and Amyloid Burden in Patients With Alzheimer's Disease
NCT01636596
Insulin LISPRO
Runs in: United States · 1 site 		NA
other		 WITHDRAWN 0 Louisiana State University Health Sciences Center Shreveport
OTHER		 2014-03-13
Evaluation of an Intervention for Living With Mild Cognitive Impairment
NCT02083237
Behavioural Intervention Program
Runs in: Canada · 1 site 		NA
other		 UNKNOWN 120 Baycrest
OTHER		 2014-03-11
Treating Behavioral Disturbances in Individuals With Dementia
NCT00073658
Citalopram; Risperidone
Runs in: United States · 1 site 		PHASE2
other		 COMPLETED 137 University of Pittsburgh
OTHER		 2014-03-10
Evaluation of a Handheld Event Related Potential (ERP)/Quantitative Electroencephalography (qEEG) System (COGNISION™) as a Useful Cognitive Biomarker for Alzheimer's Disease.
NCT00938665
COGNISION™ System
Runs in: United States · 7 sites 		NA
other		 COMPLETED 204 Neuronetrix, Inc.
INDUSTRY		 2014-03-10
Assess 123-I IMPY and SPECT Imaging as a Tool to Detect β-Amyloid in the Brain
NCT00287248
[123I] IMPY & SPECT Imaging
Runs in: United States · 1 site 		PHASE1
other		 COMPLETED 38 Institute for Neurodegenerative Disorders
OTHER		 2014-03-07
Treatment for Early Memory Loss
NCT00042172
Donepezil; Ginkgo Biloba Extract
Runs in: United States · 1 site 		PHASE4
symptomatic-cholinergic		 COMPLETED 40 University of Iowa
OTHER		 2014-03-03
Effect of Exercises Training in Patients With Mild Cognitive Impairment and Early Alzheimer's Disease
NCT02074215
Aerobic exercises; Stretch exercise
Runs in: Taiwan · 1 site 		NA
other		 COMPLETED 19 National Taiwan University Hospital
OTHER		 2014-02-28
Effects of Balance Training in Older Adults With Dementia
NCT02073318
Task-oriented balance training; Upper extremities exercise
Runs in: Taiwan · 1 site 		PHASE2
other		 COMPLETED 19 National Taiwan University Hospital
OTHER		 2014-02-27
The Effects of the Rivastigmine Patch on Parkinson's Disease With Memory and/or Thinking Problems
NCT00988117
Rivastigmine Patch 9.5 cm2
Runs in: United States · 1 site 		PHASE4
symptomatic-cholinergic		 COMPLETED 15 University of California, San Francisco
OTHER		 2014-02-26
The Study of microRNA 107 (miRNA 107) and Beta-amyloid Precursor Protein-cleaving Enzyme 1 (BACE1) Messenger Ribonucleic Acid (mRNA) Gene Expression in Cerebrospinal Fluid and Peripheral Blood of Alzheimer's Disease
NCT01819545
Runs in: China · 1 site 		NA
BACE-inhibitor		 UNKNOWN 300 Shanghai Mental Health Center
OTHER		 2014-02-19
Genes, Exercise, Memory and Neurodegeneration
NCT01021644
aerobic exercise-training; stretch exercise
Runs in: United States · 2 sites 		NA
other		 COMPLETED 73 Howard University
OTHER		 2014-02-14
A Pilot Trial of Interferon Beta-1a in Alzheimer's Disease
NCT01075763
Interferon beta-1a; Placebo
Runs in: Italy · 1 site 		PHASE2
other		 COMPLETED 42 Merck KGaA, Darmstadt, Germany
INDUSTRY		 2014-02-13

This table is wider than a phone screen — swipe it sideways to see the rest.

Where these trials come from

Registry
ClinicalTrials.gov, pulled through their public API (v2)
Trials in the file
7,816
Source file
trials.csv (3.8 MB, 7816 rows)
Basis
Measured These are registry records as submitted by each study's sponsor.

What could make this misleading

Sponsors enter their own data and do not always keep it current, so "recruiting" can be out of date by months or years. Enrollment figures may be targets rather than actual numbers; the downloaded file says which for each trial. Trials that were never registered do not appear at all, and the intervention class is this project's own grouping, not the registry's.

Always check the official record before acting on anything here. This is a summary, not medical advice.

Related evidence Treatments → What the drugs that finished their trials actually achieved.

From the research library

The highest-scoring studies we hold on this subject, each summarised in plain English. Scores are alzhub's usefulness score, not a verdict on the science.

Clinical trials

All 162 studies on Clinical trials →